Status:
COMPLETED
Galectin Role in Periodontal Disease
Lead Sponsor:
Fayoum University
Conditions:
Gingivitis
Periodontitis
Eligibility:
All Genders
25-60 years
Phase:
NA
Brief Summary
This study aimed at exploring the effect of nonsurgical periodontal treatment on galectin 1 and 3 GCF levels in patients having gingivitis, periodontitis stage III compared to periodontally healthy in...
Eligibility Criteria
Inclusion
- Non-smokers from both genders.
- Not suffering from systemic diseases, pregnancy/lactation.
- Not taking contraceptive pills, antibiotics, anti-inflammatory, or immunosuppressive drugs before inclusion in the study by 6 months.
- Patients with only gingivitis or periodontitis stage III.
- Periodontitis patients who did not receive any professional periodontal treatment in the last 6 months.
Exclusion
- smokers.
- having systemic diseases, pregnancy/lactation.
- taking contraceptive pills, antibiotics, anti-inflammatory, or immunosuppressive drugs in the past 6 months.
- Patients having periodontitis any other stage than stage III.
- Periodontitis patients who receive any professional periodontal treatment in the last 6 months.
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 30 2023
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06038812
Start Date
August 1 2023
End Date
September 30 2023
Last Update
January 12 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
faculty of dentistry, Fayoum university
Al Fayyum, Egypt